Table 2

Antimicrobial resistance among animal, human and miscellaneous sources of S. Senftenberg

Antimicrobial

Breakpoint

Animal

(n = 71)

Human

(n = 22)

Other

(n = 5)


Amikacin (AMI)

≥64

0

0

0

Amoxicillin/Clavulanic Acid (AUG)

≥32/16

7 (9.8%)

0

0

Ampicillin (AMP)

≥32

14 (19.7%)

0

0

Cefoxitin (FOX)

≥32

8 (11.2%)

0

0

Ceftiofur (TIO)

≥8

8 (11.2%)

0

0

Ceftriaxone (AXO)

≥4

8 (11.2%)

0

0

Chloramphenicol (CHL)

≥32

11 (15.4%)

0

0

Ciprofloxacin (CIP)

≥4

0

0

0

Gentamicin (GEN)

≥16

13 (18.3%)

0

1 (20%)

Kanamycin (KAN)

≥64

26 (36.6%)

0

1 (20%)

Nalidixic Acid (NAL)

≥32

0

0

0

Streptomycin (STR)

≥64

21 (29.5%)

0

1 (20%)

Sulfisoxazole (FIS)

≥256

37 (52.1%)

0

1 (20%)

Tetracycline (TET)

≥16

34 (47.8%)

0

1 (20%)

Trimethroprim/Sulfamethoxazole (SXT)

≥4/76

11 (15.4%)

0

0


Stepan et al. BMC Microbiology 2011 11:153   doi:10.1186/1471-2180-11-153

Open Data